Effect of ACTH and CRH on plasma levels of cortisol and prostaglandin F2alpha metabolite in cycling gilts and castrated boars.
The present study was designed to evaluate the effects of synthetic ACTH (1-24, tetracosactid) and porcine CRH on the plasma levels of cortisol and PGF2alpha metabolite in cycling gilts (n = 3) and castrated boars (n = 3). The experiments were designed as crossover studies for each gender separately. Each animal received, during three consecutive days; 1) ACTH (Synacthen Depot) at a dose of 10 microg/kg body weight in 5 ml physiological saline, 2) porcine CRH at a dose 0.6 microg/kg body weight in 5 ml physiological saline or 3) physiological saline (5 ml). The test substances were administered via an indwelling jugular cannula in randomized order according to a Latin square. The administration of ACTH to cycling gilts resulted in concomitant elevations of cortisol and PGF2alpha metabolite with peak levels reached at 70.0 +/- 10.0 and 33.3 +/- 6.7 min, respectively. Similarly, the administration of ACTH to castrated boars resulted in concomitant elevation of cortisol and PGF2alpha metabolite with peak levels reached at 60.0 +/- 0.0 and 20.0 +/- 0.0 min, respectively. Cortisol peaked at 20 min after administration of CRH in both cycling gilts and castrated boars with maximum levels of 149.3 +/- 16.5 nmol/l and 138.3 +/- 10.1 nmol/l, respectively. It can be concluded that administration of synthetic ACTH (tetracosactid) to pigs caused a concomitant elevation of cortisol and PGF2alpha metabolite levels in both cycling gilts as well as castrated boars. The administration of CRH to pigs resulted in an elevation of cortisol levels in both cycling gilts and castrated boars. Conversely, PGF2alpha metabolite levels were not influenced by the administration of CRH either in cycling gilts or in castrated boars.
Madej
A
A
Department of Anatomy and Physiology, Centre for Reproductive Biology in Uppsala, Swedish University of Agricultural Sciences (SLU), P.O. Box 7011, SE- 750 07 Uppsala, Sweden. Andrzej.Madej@afys.slu.se
Mwanza
A M
AM
Kindahl
H
H
Einarsson
S
S
D000324:Adrenocorticotropic Hormone / Q000494:pharmacology*; D000818:Animals; D019540:Area Under Curve; D003346:Corticotropin-Releasing Hormone / Q000494:pharmacology*; D018592:Cross-Over Studies; D015237:Dinoprost / Q000097:blood*; D005260:Female; D006854:Hydrocortisone / Q000097:blood*; D008297:Male; D009919:Orchiectomy / Q000662:veterinary; D011897:Random Allocation; D013552:Swine / Q000097:blood*
D000324:Adrenocorticotropic Hormone; D003346:Corticotropin-Releasing Hormone; D015237:Dinoprost; D006854:Hydrocortisone